A biomedical startup with 100 years of experience
GeneSys Bio was born from thegroup’s many years of experience in both diagnostic-medical and medical device development.
The “biotech“team has gained more than 50 years of experience in rapid diagnostics and molecular biology test development.
The “device” team, more than 65 years strong in the industry, helps develop reliable, low-maintenance and affordable products.
Our team
Infectious diseases, oncology, applied engineering, business and marketing.
More than 10 patents, more than 30 scientific publications.
The background of our team has in its diversity its greatest strength.
The experience accumulated over time by each of GeneSys Bio’s members is poured into the project, bringing added value to each of its steps.
Andrea Faviere
CEO
MBA-EMBA LS COMPANY MANAGEMENT
10 YEARS IN BD, MKTG & SALES
Henry Di Oto
COO | Investor Relations
BS, MD, PHD 18 YEARS IN HOSPITAL DIAGNOSIS ENTREPRENEUR
Simone Di Giacomo
CSO
BS, PHD > 15 YEARS IN ACADEMIC & CORPORATE R&D
Luciano Ranieri
CTO
50 YEARS IN MEDICAL DEVICE AND DEVICE DEVELOPMENT
Andrea Faviere
CEO
MBA-EMBA LS COMPANY MANAGEMENT
10 YEARS IN BD, MKTG & SALES
Henry Di Oto
COO | Investor Relations
BS, MD, PHD 18 YEARS IN HOSPITAL DIAGNOSIS ENTREPRENEUR
Simone Di Giacomo
CSO
BS, PHD > 15 YEARS IN ACADEMIC & CORPORATE R&D
Luciano Ranieri
CTO
50 YEARS IN MEDICAL DEVICE AND DEVICE DEVELOPMENT
Those who believe in our project:
OaCP IE Ltd
Company leader in rapid diagnostics has chosen GeneSys Bio for its capabilities to implement infection monitoring.
Cassa Depositi e Prestiti
Cassa Depositi e Prestiti is theItalian National Promotion Institute. Chose to invest in GeneSys Bio, believing it to be a valuable tool for improving healthcare through innovation
AC75 Startup Accelerator
GeneSys Bio was chosen by AC75, a Silver Economy-focused institution and the first of its kind in Europe, after careful evaluation of the team’s skills and the impact the project will have on the target population.